Literature DB >> 6430948

Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery.

U M Kabadi.   

Abstract

Altered thyroid hormone metabolism with decreased serum T3 and increased rT3 concentrations in patients with uncontrolled diabetes mellitus has been well documented. However, data regarding TSH secretion are sparse, especially the influence of glycemic control. Therefore, we examined serum T4, free T4, T3, rT3, T3 resin uptake, and TSH as well as the TSH response to TRH administration [expressed as TSH increment (delta TSH) and area under the curve (theta TSH)] in 29 newly discovered type II diabetic patients (DM) before treatment and in 12 normal subjects. The study was repeated in the DM patients after attainment of euglycemia and normalization of glycosylated hemoglobin (HbA1C) following therapy with diet and tolazamide for 8-12 weeks. Serum T4, free T4, and T3 resin uptake were not significantly different in DM compared to those in normal subjects. Serum T3 was low and rT3 was high in DM before treatment, and both normalized on achieving the euglycemic state. Basal TSH in uncontrolled DM was not significantly different from that in normal subjects and remained unchanged during treatment. However, delta TSH and theta TSH were significantly reduced (P less than 0.01) in uncontrolled DM. Both fasting plasma glucose (FBS) and HbA1C levels correlated inversely with delta TSH as well as theta TSH (FBS vs. delta TSH, r = -0.42; FBS vs. theta TSH, r = -0.38; HbA1C vs. delta TSH, r = -0.40; HbA1C vs. theta TSH, r = -0.42; P less than 0.05 for all correlations). Finally, TSH responses returned to normal on attainment of euglycemia and normal HbA1C concentrations. These studies indicate that regulation of TSH secretion is altered in DM during the decompensated state and normalizes when euglycemia is achieved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430948     DOI: 10.1210/jcem-59-3-521

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Impaired thyrotrophin secretion following the administration of thyrotrophin-releasing hormone in type II diabetes mellitus.

Authors:  M Small; H N Cohen; J A MacLean; G H Beastall; A C MacCuish
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

2.  Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Authors:  Arnaldo Moura Neto; Maria Candida Ribeiro Parisi; Sarah Monte Alegre; Elizabeth Joao Pavin; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.633

3.  Thyrotropin dysregulation during a non-thyroidal illness: transient hypothalamic hypothyroidism?

Authors:  U M Kabadi
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

4.  Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.

Authors:  A Moura Neto; M C R Parisi; M A Tambascia; E J Pavin; S M Alegre; D E Zantut-Wittmann
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

Review 5.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

6.  TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability.

Authors:  G Bellastella; M I Maiorino; L Scappaticcio; O Casciano; M Petrizzo; M Caputo; V A Paglionico; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2017-08-30       Impact factor: 4.256

7.  The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.

Authors:  C Shigemasa; K Abe; S Taniguchi; Y Mitani; Y Ueta; T Adachi; K Urabe; T Tanaka; A Yoshida; T Hori
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

8.  Low-normal free thyroxine confers decreased serum bilirubin in type 2 diabetes mellitus.

Authors:  Petronella E Deetman; Arjan J Kwakernaak; Stephan J L Bakker; Robin P F Dullaart
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

9.  THYROID HORMONES IN NON-INSULIN-DEPENDENT DIABETES BEFORE AND AFTER THERAPY.

Authors:  J S Saini; S Naqvi; O P Dutt
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 10.  Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Authors:  Arnaldo Moura Neto; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2016-10-10       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.